Glioma natural history, complications and prognosis

	Glioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Glioma natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Glioma natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Glioma natural history, complications and prognosis
CDC on Glioma natural history, complications and prognosis
Glioma natural history, complications and prognosis in the news
Blogs on Glioma natural history, complications and prognosis
Directions to Hospitals Treating Glioma
Risk calculators and risk factors for Glioma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Common complications of glioma include brain herniation, hydrocephalus, coma, metastasis, recurrence, side effects of chemotherapy, and side effects of radiation therapy. The prognosis of glioma varies with the grade of tumor. The 1-year and 2-year survival rate of patients with malignant glioma is approximately 50% and 25%, respectively.^[1]

Common complications of glioma include:

The prognosis of glioma varies with the grade of tumor: WHO grade 1 and WHO grade 4 have the most favorable and worst prognosis, respectively.
The 1-year and 2-year survival rate of patients with malignant glioma is approximately 50% and 25%, respectively.
Post-operative radiation therapy is often used as an adjunct to surgery in the treatment of high-grade gliomas as it has shown to double the median survival for high-grade gliomas to 37 weeks (versus 17 weeks with surgery alone).
The prognosis of glioma may depend on other factors which include:^[1]

DNA methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter
Mutation of isocitrate dehydrogenase: IDH1 or IDH2 genes
Codeletion of chromosomes 1p and 19q